Immix Biopharma, Inc.IMMXNASDAQ
Loading
Operating Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+43.0%
5Y CAGR+121.2%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+43.0%/yr
Annual compound
5Y CAGR
+121.2%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
53x
Strong expansion
Streak
5 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $24.05M | +6.1% |
| 2024 | $22.67M | +40.5% |
| 2023 | $16.14M | +96.4% |
| 2022 | $8.22M | +507.9% |
| 2021 | $1.35M | +197.9% |
| 2020 | $453852.00 | -46.1% |
| 2019 | $842499.00 | - |